Back to UBS Group AG UBS Group AG

MRSNMRSN
Showing 7 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in MERSANA THERAPEUTICS INC

UBS Group AG previously held 0 shares of MRSN (MERSANA THERAPEUTICS INC), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$894,966

Total Shares Change

-473,527

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$29.08
0
2025-Q4
Decreased
221
-97.4%
$6,3940.0%$28.65
0
2025-Q3
Decreased
8,609
-98.9%
$66,8050.0%$7.79
0
2025-Q2
Increased
775,501
+142.5%
$229,5490.0%$7.28
25
2025-Q1
Increased
319,805
+97.1%
$110,0130.0%$9.49
24
2024-Q4
Decreased
162,264
-65.7%
$232,0370.0%$35.50
0
2024-Q3
Increased
473,527
+1253.6%
$894,9660.0%$46.25
40

Other major holders of MRSN: BNP PARIBAS FINANCIAL MARKETS, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used